Weightlifter Danielle Rante, of Dayton, Ohio and Taff Woolsey, of Port Orchard, Washington accepts sanction for Anti-Doping Rule Violation.
COLORADO SPRINGS,–United States Andi-Doping Agency (USADA) announced today that an independent arbitrator has rendered a decision in the case of UFC® athlete Gilbert Melendez, of Brisbane, California., and determined that Melendez should receive a two-year period of ineligibility for his anti-doping policy violation, precluding him from competing in any UFC bouts. This decision comes after the facts of the case were presented and argued.
Meanwhile two US weightlifters Danielle Rante and Taff Woolseyaccepted sanctions for four and two years, respectively, for Anti-Doping Rule Violation, according to information provided by USADA.
Melendez, 38, tested positive for GHRP-6 and its metabolites GHRP-6(2-5)-OH and GHRP-6(2-6)-OH as the result of a urine sample collected out-of-competition on October 16, 2019. GHRP-6 is a
non-Specified Substance in the class of Peptide Hormones, Growth Factors, Related Substances, and Mimetics, and is prohibited at all times under the UFC Anti-Doping Policy and UFC Prohibited List.
While Melendez did not contest the presence of GHRP-6 and its metabolites in his sample nor identify a source of the prohibited peptide, he did challenge USADA’s jurisdiction to conduct the test.
The arbitrator concluded that USADA did have jurisdiction to both conducts the test and allege an anti-doping policy violation in the event of a positive sample, as was the case.
Melendez’s two-year period of ineligibility began on November 1, 2019, the date his provisional suspension was imposed. .
USADA also announced that weightlifter Danielle Rante, of Dayton, Ohio, has accepted a four-year suspension for an anti-doping rule violation.
Rante, 40, tested positive for 19-norandrosterone (19-NA), the main urinary metabolite of nandrolone (19-nortestosterone) and other 19-norsteroids, as a result of an out-of-competition drug test
conducted on March 4, 2020.
19-NA is a Non-Specified Substance in the class of Anabolic Agents and is prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic and Paralympic
Committee National Anti-Doping Policies, and the International Weightlifting Federation Anti-Doping Policy, all of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency, Prohibited List. Anabolic agents have powerful performance-enhancing capabilities
and can give an athlete an unfair advantage over fellow competitors. Rante’s four-year period of ineligibility began on March 4, 2020, the date her positive sample was collected. In addition, Rante has been disqualified from all competitive results obtained on and subsequent to March 4, 2020, including forfeiture of any medals, points and prizes.
USADA announced today that weightlifterTaff Woolsey, of Port Orchard, Washington has accepted a two-year suspension for an anti-doping rule violation involving his possession of a prohibited substance.
This type of non-analytical information prompted an investigation into Woolsey’s case, during which USADA obtained specific and credible evidence that starting on February 17, 2018, Woolsey, 48, purchased a product containing exemestane.
Exemestane is a Specified Substance in the class of Hormone and Metabolic Modulators and is prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic and Paralympic Committee National Anti-Doping Policy, and the International Weightlifting Federation Anti-Doping Policy, all of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency, Prohibited List. Woolsey’s two-year period of ineligibility began on July 17, 2020, the date he accepted a sanction. In addition, Woolsey has been disqualified from competitive results obtained on and subsequent to February 17, 2018, the date he purchased exemestane, including
forfeiture of any medals, points and prizes.